Literature DB >> 20536716

Dietary fructose exacerbates hepatocellular injury when incorporated into a methionine-choline-deficient diet.

Michael K Pickens1, Hisanobu Ogata, Russell K Soon, James P Grenert, Jacquelyn J Maher.   

Abstract

BACKGROUND: Methionine-choline-deficient (MCD) diets cause steatohepatitis in rodents and are used to model fatty liver disease in human beings. Recent studies have identified sucrose as a major contributor to MCD-related liver disease through its ability to promote hepatic de novo lipogenesis. AIMS: To determine whether glucose and fructose, the two constitutents of sucrose, differ in their capacity to provoke steatohepatitis when incorporated individually into MCD formulas. MATERIALS &
METHODS: MCD and control formulas prepared with either glucose or fructose as the sole source of carbohydrate were fed to mice for 21 days. Liver injury was assessed biochemically and histologically together with hepatic gene expression and fatty acid analysis.
RESULTS: Mice fed MCD formulas developed similar degrees of hepatic steatosis whether they contained glucose or fructose. By contrast, mice fed MCD-fructose developed significantly more hepatocellular injury than mice fed MCD-glucose, judged by histology, apoptosis staining and serum alanine aminotransferase. Liver injury in MCD-fructose mice coincided with an exaggerated rise in the ratio of long-chain saturated to unsaturated fatty acids in the liver. Notably, hepatic inflammation was not enhanced in mice fed MCD-fructose, correlating instead with hepatic lipid peroxidation, which was equivalent in the two MCD groups. DISCUSSION: Fructose is more cytotoxic than glucose when used as the source of carbohydrate in MCD formulas.
CONCLUSION: The data suggest the enhanced cytotoxicity of fructose in the MCD model is related to its ability to stimulate de novo lipogenesis, which yields harmful long-chain saturated fatty acids.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20536716      PMCID: PMC3592570          DOI: 10.1111/j.1478-3231.2010.02285.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  43 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream.

Authors:  David G Ginzinger
Journal:  Exp Hematol       Date:  2002-06       Impact factor: 3.084

3.  CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis.

Authors:  I A Leclercq; G C Farrell; J Field; D R Bell; F J Gonzalez; G R Robertson
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

4.  Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection.

Authors:  H Bantel; A Lügering; C Poremba; N Lügering; J Held; W Domschke; K Schulze-Osthoff
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

5.  Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis.

Authors:  Michael K Pickens; Jim S Yan; Raymond K Ng; Hisanobu Ogata; James P Grenert; Carine Beysen; Scott M Turner; Jacquelyn J Maher
Journal:  J Lipid Res       Date:  2009-03-17       Impact factor: 5.922

Review 6.  Regulation of stearoyl-CoA desaturases and role in metabolism.

Authors:  James M Ntambi; Makoto Miyazaki
Journal:  Prog Lipid Res       Date:  2004-03       Impact factor: 16.195

7.  The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance.

Authors:  Mary E Rinella; Richard M Green
Journal:  J Hepatol       Date:  2004-01       Impact factor: 25.083

8.  Stearoyl-CoA desaturase 1 gene expression is necessary for fructose-mediated induction of lipogenic gene expression by sterol regulatory element-binding protein-1c-dependent and -independent mechanisms.

Authors:  Makoto Miyazaki; Agnieszka Dobrzyn; Weng Chi Man; Kiki Chu; Harini Sampath; Hyoun-Ju Kim; James M Ntambi
Journal:  J Biol Chem       Date:  2004-04-05       Impact factor: 5.157

9.  A choline-deficient diet in mice inhibits neither the CDP-choline pathway for phosphatidylcholine synthesis in hepatocytes nor apolipoprotein B secretion.

Authors:  Agnes Kulinski; Dennis E Vance; Jean E Vance
Journal:  J Biol Chem       Date:  2004-03-15       Impact factor: 5.157

10.  The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse.

Authors:  Ali Canbay; Ariel Feldstein; Edwina Baskin-Bey; Steven F Bronk; Gregory J Gores
Journal:  J Pharmacol Exp Ther       Date:  2003-11-14       Impact factor: 4.030

View more
  17 in total

Review 1.  Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease.

Authors:  Rebecca C Schugar; Peter A Crawford
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2012-07       Impact factor: 4.294

2.  High-fat and obesogenic diets: current and future strategies to fight obesity and diabetes.

Authors:  João S Teodoro; Ana T Varela; Anabela P Rolo; Carlos M Palmeira
Journal:  Genes Nutr       Date:  2014-05-20       Impact factor: 5.523

Review 3.  New insights from rodent models of fatty liver disease.

Authors:  Jacquelyn J Maher
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

4.  Isocaloric manipulation of macronutrients within a high-carbohydrate/moderate-fat diet induces unique effects on hepatic lipogenesis, steatosis and liver injury.

Authors:  Andrew A Pierce; Caroline C Duwaerts; Russell K Soon; Kevin Siao; James P Grenert; Mark Fitch; Marc K Hellerstein; Carine Beysen; Scott M Turner; Jacquelyn J Maher
Journal:  J Nutr Biochem       Date:  2015-11-17       Impact factor: 6.048

Review 5.  Characterization of diet based nonalcoholic fatty liver disease/nonalcoholic steatohepatitis in rodent models: Histological and biochemical outcomes.

Authors:  Ghaidafeh Akbari; Seyyed Ali Mard; Feryal Savari; Barat Barati; Maryam J Sameri
Journal:  Histol Histopathol       Date:  2022-04-27       Impact factor: 2.130

6.  High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase.

Authors:  Takuji Ishimoto; Miguel A Lanaspa; Christopher J Rivard; Carlos A Roncal-Jimenez; David J Orlicky; Christina Cicerchi; Rachel H McMahan; Manal F Abdelmalek; Hugo R Rosen; Matthew R Jackman; Paul S MacLean; Christine P Diggle; Aruna Asipu; Shinichiro Inaba; Tomoki Kosugi; Waichi Sato; Shoichi Maruyama; Laura G Sánchez-Lozada; Yuri Y Sautin; James O Hill; David T Bonthron; Richard J Johnson
Journal:  Hepatology       Date:  2013-10-08       Impact factor: 17.425

7.  Role of choline deficiency in the Fatty liver phenotype of mice fed a low protein, very low carbohydrate ketogenic diet.

Authors:  Rebecca C Schugar; Xiaojing Huang; Ashley R Moll; Elizabeth M Brunt; Peter A Crawford
Journal:  PLoS One       Date:  2013-08-29       Impact factor: 3.240

8.  Differential hepatotoxicity of dietary and DNL-derived palmitate in the methionine-choline-deficient model of steatohepatitis.

Authors:  Andrew A Pierce; Michael K Pickens; Kevin Siao; James P Grenert; Jacquelyn J Maher
Journal:  BMC Gastroenterol       Date:  2015-06-24       Impact factor: 3.067

Review 9.  Reactive oxygen species, nutrition, hypoxia and diseases: Problems solved?

Authors:  Agnes Görlach; Elitsa Y Dimova; Andreas Petry; Antonio Martínez-Ruiz; Pablo Hernansanz-Agustín; Anabela P Rolo; Carlos M Palmeira; Thomas Kietzmann
Journal:  Redox Biol       Date:  2015-08-28       Impact factor: 11.799

Review 10.  Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse.

Authors:  Jesse D Riordan; Joseph H Nadeau
Journal:  Mamm Genome       Date:  2014-05-07       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.